Compounds > etoposide
Page last updated: 2024-08-23

etoposide and fosbretabulin

etoposide has been researched along with fosbretabulin in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (16.67)29.6817
2010's11 (61.11)24.3611
2020's4 (22.22)2.80

Authors

AuthorsStudies
Artico, M; Brancale, A; Coluccia, A; De Martino, G; Díaz, JF; Edler, MC; Hamel, E; Kandil, S; La Regina, G; Lavecchia, A; Matesanz, R; Novellino, E; Piscitelli, F; Prosperi, E; Scovassi, AI; Silvestri, R1
Chang, CY; Chang, JY; Chiang, YK; Coumar, MS; Hsieh, HP; Kuo, CC; Lai, MJ; Liou, JP; Reddy, GR; Tan, UK; Wu, SY; Yeh, JY1
Janaki Ramaiah, M; Kamal, A; Kumar, BA; Lavanya, A; Mallareddy, A; Pal-Bhadra, M; Pushpavalli, SN; Raju, P; Sarma, P; Suresh, P; Vinay Gopal, J1
Chang, CY; Chang, JY; Kuo, CC; Lai, WY; Lee, HY; Liou, JP; Nien, CY; Shih, KH; Wu, CH1
Budovská, M; Mezencev, R; Mojžiš, J; Pilátová, M; Varinská, L1
Chang, CY; Chang, JY; Chang, YT; Kuo, CC; Lai, MJ; Lee, HY; Liou, JP; Liu, YM; Mehndiratta, S; Nien, CY; Pan, SL; Su, MC; Wu, JS; Wu, SY1
Chang, CY; Chang, JY; Chuang, HY; Kuo, CC; Lee, HY; Liou, JP; Yeh, TK1
Chang, CY; Chang, JY; Chen, MC; Chiang, YF; Kuo, CC; Lai, MJ; Lee, HY; Liou, JP; Mehndiratta, S1
Das, A; Dhoke, NR; Duscharla, D; Ramasatyaveni, G; Shareef, MA; Srivastava, AK; Ummanni, R1
Chang, CY; Chang, JY; Chuang, HY; Kuo, CC; Lai, MJ; Lee, HY; Liou, JP1
Amrutkar, SM; Banerjee, UC; Das, S; Guchhait, SK; Kundu, CN; Nayak, A; Priyadarshani, G1
Cho, WJ; Han, J; Jin, Y; Khadka, DB; Kwon, Y; Park, S1
Diao, Q; Gao, F; Gao, M; Sun, Z; Wang, P; Xiao, J1
Bouchard, M; Fortin, S; Gagné-Boulet, M; Giguère, D; Paré-Lacroix, MP; Tremblay, T1
Przybylski, P; Łowicki, D1
Guo, H; Sun, S; Wang, G1
Bates, SE; Baumeister, P; Costa, F; Dong, D; Ko, B; Lee, AS; Markland, F; Patterson, JB; Stiles, C; Swenson, S1
Bohndiek, SE; Booth, TC; Brindle, KM; Canuto, HC; Hobson, MP; Hu, DE; Kettunen, MI; Krishnan, AS; Larkin, TJ; McLachlan, C; Neves, AA1

Reviews

3 review(s) available for etoposide and fosbretabulin

ArticleYear
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
    European journal of medicinal chemistry, 2020, Dec-15, Volume: 208

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Molecular Structure; Podophyllotoxin; Stereoisomerism; Structure-Activity Relationship

2020
Cascade synthetic strategies opening access to medicinal-relevant aliphatic 3- and 4-membered N-heterocyclic scaffolds.
    European journal of medicinal chemistry, 2022, Aug-05, Volume: 238

    Topics: Bridged Bicyclo Compounds; Nitrogen

2022
Current status of carbazole hybrids as anticancer agents.
    European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

    Topics: Antineoplastic Agents; Carbazoles; Cell Cycle Checkpoints; Cell Proliferation; Coumarins; Humans; Indoles; Pyrazoles; Pyrimidines; Structure-Activity Relationship

2022

Other Studies

15 other study(ies) available for etoposide and fosbretabulin

ArticleYear
Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.
    Journal of medicinal chemistry, 2007, Jun-14, Volume: 50, Issue:12

    Topics: Apoptosis; Biopolymers; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Hydrogen Bonding; Indoles; Models, Molecular; Protein Binding; Radioligand Assay; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2007
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
    Journal of medicinal chemistry, 2008, Dec-25, Volume: 51, Issue:24

    Topics: Anisoles; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Inhibitory Concentration 50; Models, Chemical; Naphthalenes; Neoplasms; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2008
Synthesis and biological evaluation of 4β-acrylamidopodophyllotoxin congeners as DNA damaging agents.
    Bioorganic & medicinal chemistry, 2011, Aug-01, Volume: 19, Issue:15

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Comet Assay; DNA; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Neoplasms; Podophyllotoxin

2011
5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2.
    Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24

    Topics: Aminoquinolines; Angiogenesis Inhibitors; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Hydroxyquinolines; Quinolines; Stilbenes; Structure-Activity Relationship; Sulfones; Tubulin Modulators

2011
The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin.
    Bioorganic & medicinal chemistry, 2013, Nov-01, Volume: 21, Issue:21

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Jurkat Cells; Magnetic Resonance Spectroscopy; MCF-7 Cells; Phytoalexins; Sesquiterpenes; Stereoisomerism; Thiocarbamates

2013
Furanylazaindoles: potent anticancer agents in vitro and in vivo.
    Journal of medicinal chemistry, 2013, Oct-24, Volume: 56, Issue:20

    Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Female; Heterocyclic Compounds, 2-Ring; HT29 Cells; Humans; Indoles; Inhibitory Concentration 50; Mice, Nude; Molecular Structure; Neoplasms; Polymerization; Sulfonamides; Tubulin; Xenograft Model Antitumor Assays

2013
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones.
    European journal of medicinal chemistry, 2014, Apr-22, Volume: 77

    Topics: Antimitotic Agents; Benzophenones; Cell Line, Tumor; Cell Proliferation; Colchicine; Dose-Response Relationship, Drug; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; KB Cells; Molecular Structure; Polymerization; Structure-Activity Relationship; Tubulin

2014
Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents.
    Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17

    Topics: Antineoplastic Agents; Capillaries; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Indoles; KB Cells; Mitosis; Molecular Structure; Polymerization; Structure-Activity Relationship; Sulfonamides; Tubulin; Tubulin Modulators

2014
Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
    European journal of medicinal chemistry, 2015, Jan-07, Volume: 89

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esters; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2015
Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes.
    Bioorganic & medicinal chemistry, 2015, Aug-01, Volume: 23, Issue:15

    Topics: Angiogenesis Inhibitors; Antimitotic Agents; Benzene; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Colchicine; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Structure-Activity Relationship; Tubulin Modulators

2015
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-
    ACS medicinal chemistry letters, 2016, Dec-08, Volume: 7, Issue:12

    Topics:

2016
Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Antineoplastic Agents; Biocatalysis; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Molecular Structure; Polymerization; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tubulin

2018
Synthetic development of sugar amino acid oligomers towards novel podophyllotoxin analogues.
    Bioorganic & medicinal chemistry, 2021, 12-15, Volume: 52

    Topics: Amino Acids; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Development; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Sugars

2021
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
    Cancer research, 2005, Jul-01, Volume: 65, Issue:13

    Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Disintegrins; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Etoposide; Female; Glucose; Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Chaperones; Neovascularization, Pathologic; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Stilbenes; Transcriptional Activation; Transfection; Xenograft Model Antitumor Assays

2005
Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment.
    Magnetic resonance in medicine, 2014, Volume: 71, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Etoposide; Female; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasm Staging; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Stilbenes; Treatment Outcome

2014